4-Aminobutyrate Aminotransferase (ABAT): Genetic and Pharmacological Evidence for an Involvement in Gastro Esophageal Reflux Disease
Johan Jirholt, Maria Lagerström‐Fermér(AstraZeneca (Sweden)), Paul Hammond(Women's and Children's Hospital), Bengt Åsling(AstraZeneca (Sweden)), Jörgen Jensen, Mikael Knutsson(Hôpital Bichat-Claude-Bernard), Geoffrey P. Davidson(The University of Adelaide), Lars Agréus(The University of Sydney), Anders Lehmann(AstraZeneca (United Kingdom)), Anna Walentinsson(AstraZeneca (Sweden))
Cited by 11
Related Papers
Large-scale association analyses identify host factors influencing human gut microbiome composition
|Nature Genetics|2021|1.9k
Ischemia-Induced Shift of Inhibitory and Excitatory Amino Acids from Intra- to Extracellular Compartments
|Journal of Cerebral Blood Flow & Metabolism|1985|660
AGA technical review: Evaluation of dyspepsia
|Gastroenterology|1998|438